Immunohistochemical analysis of Fas ligand expression in sarcomas. Sarcomas express high level of FasL in vivo

APMIS

Volumn 106, Issue 11, 1998, Pages 1035-1040

  Lee, Sug Hyung ^a   Jang, Ja June ^b   Lee, Jung Young ^a   Kim, Soo Young ^a   Park, Won Sang ^a   Kim, Choo Soung ^a   Kim, Sang Ho ^a   Yoo, Nam Jin ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Fas; Fas ligand; Immunohistochemistry; Sarcoma

Indexed keywords

ARTICLE; CHONDROSARCOMA; DERMATOFIBROMA; EWING SARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; NEURILEMOMA; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; TUMOR BIOPSY;

EID: 0037684057     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb00255.x     Document Type: Article

References (28)

1. Arai, H., Gordon, D., Nabel, E. G. & Nabel, G. J.: Gene transfer of Fas ligand induces tumor regression in vivo. Proc. Natl. Acad. Sci. USA 94: 13862-13867, 1997.
2. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A. & Duke, R. C.: A role for CD95 ligand in preventing graft rejection. Nature 377: 630-632, 1995.
3. Cordon-Cardo, C., Fuks, Z., Drobnjak, M., Moreno, C., Eisenbach, L. & Felman, M.: Expression of HLA-A, B, C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res. 51: 6372-6380, 1991.
4. French, L. E., Hahne, M., Viard, G., Radlgruber, R., Zanone, K., Becker, C., Müller, C. & Tschopp, J.: Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privilege tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol. 133: 335-343, 1996.
5. Gonzalez-Cuadrado, S., Lorz, C., Garcia del Moral, R., O'Valle, F., Ortiz-Gonzalez, A., Edigo, J. & Ortiz, A.: Agonistic anti-Fas antibodies induce glomerular cell apoptosis in mice in vivo. Kidney Int. 51: 1739-1746, 1997.
6. Griffith, T., Brunner, T., Fletcher, S., Green, D. & Ferguson, T.: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192, 1995.
7. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornund, T., Fontana, A., Lienard, D., Cerottini, J. C. & Tschopp, J.: Melanoma cell expression on Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274: 1363-1366, 1996.
8. Hunt, J. S., Vassmer, D., Ferguson, T. A. & Miller, L.: Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol. 158: 4122-4128, 1997.
9. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J. L., Burns, K., Mattmann, C., Rimoldi, D., French, L. E. & Tschopp, J.: Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195, 1997.
10. Kerstens, H. M. G., Poddighe, P. J. & Hansellar, A. G. J. M.: Novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramide. J. Histochem. Cytochem. 43: 347-352, 1995.
11. Leithäuser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Brüderlein, S., Henne, C., Schmidt, A., Debatin, K. M., Krummer, P. H. & Möller, P.: Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69: 415-429, 1993.
12. Midis, G. P., Shen, Y. & Owen-Schaub, L. B.: Elevated soluble Fas (sFas) level in nonhematopoietic human malignancy. Cancer Res. 56: 3870-3874, 1996.
13. Nagata, S.: Apoptosis by death factor. Cell 88: 355-365, 1997.
14. Niehans, G. A., Brunner, T., Frizelle, S. P., Liston, J. C., Salerno, C. T., Knapp, D. J., Green, D. R. & Kratzke, R. A.: Human lung carcinomas express Fas ligand. Cancer Res. 57: 1007-1012, 1997.
15. O'Connell, J., O'Sullivan, G. C., Collins, J. K. & Shanahan, F.: The Fas counterattack: Fas-mediated T cell killing by colon cells expressing Fas ligand. J. Exp. Med. 184: 1075-1082, 1996.
16. Ogasawara, J., Watanabe, F. R., Adachi, M., Matsuzawa, A., Kusugai, T., Kitamura, Y., Itoh, N., Suda, T. & Nagata, S.: Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809, 1993.
17. Owen-Schaub, L. B., Yonehara, S., Crump, W. L. & Grimm, E. A.: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140: 197-205, 1992.
18. Owen-Schaub, L. B., Radinsky, R., Kruzel, E., Berry, K. & Yonehara, S.: Anti-Fas on non-hematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responses. Cancer Res. 54: 1580-1586, 1994.
19. Pardoll, D. M.: Tumor antigens: a new look for the 1990s. Nature 369: 357-358, 1994.
20. Perzova, R. & Loughran, T. P.: Constitutive expression of Fas ligand in large granular lymphocyte leukemia. Br. J. Haematol. 97: 123-126, 1997.
21. Saas, P., Walker, P. R., Hahne, M., Quiquerez, A. L., Schnuriger, V., Perrin, G., French, L., Meir, E. G. V., Tribolet, N. D., Tschopp, J. & Dietrich, P. V.: Fas ligand expression by astrocytoma in viva: Maintaining immune privilege in the brain? J. Clin. Invest. 99: 1173-1178, 1997.
22. Sato, T., Irie, S., Kituda, S. & Reed, J. C.: FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268: 411-415, 1995.
23. Shiraki, K., Tsuji, N., Shioda, T., Isselbacher, K. J. & Takahashi, H.: Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc. Natl. Acad. Sci. USA 94: 6420-6425, 1997.
24. Suda, T., Takahashi, T., Golstein, P. & Nagata, S.: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178, 1993.
25. Suda, T. & Nagata, S.: Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179: 873-879, 1994.
26. Sulitzeanu, D.: Immunosuppressive factors in human cancer. Adv. Cancer Res. 60: 247-271, 1993.
27. Trauth, B. C., Klas, C., Peters, A. M. J., Matzku, S., Moller, P., Falk, W., Debatin, K.-M. & Krummer, P. H.: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305, 1989.
28. Yonehara, S., Ishii, A. & Yonehara, M.: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169: 1747-1756, 1989.